Portfolio company
DC Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
Nomic Bio
Nomic Bio develops high-throughput protein profiling platforms and assays for pharmaceutical, biotechnology and academic researchers to accelerate drug and biomarker discovery.
